REQUEST A DEMO
Total
USD $0.00
Search more companies

Dixons Pharmaceuticals Cz S.R.O. (Czech Republic)

Main Activities: Medical Equipment and Supplies Manufacturing | Surgical and Medical Instrument Manufacturing
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | General Merchandise Stores, including Warehouse Clubs and Supercenters | Professional, Scientific, and Technical Services
Full name: Dixons Pharmaceuticals Cz S.R.O. Profile Updated: October 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dixons Pharmaceuticals Cz S.R.O. is based in Czech Republic. The head office is in Prague. The company operates in the Medical Equipment and Supplies Manufacturing sector. It was established on February 01, 2021. From the latest financial highlights, Dixons Pharmaceuticals Cz S.R.O. reported a net sales revenue drop of 29.28% in 2024. During that time, Dixons Pharmaceuticals Cz S.R.O.’s total assets decreased by 21.63%. The net profit margin of Dixons Pharmaceuticals Cz S.R.O. decreased by 5.36% in 2024.

Headquarters
Kaprova 42/14
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Dixons Pharmaceuticals Cz S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Dixons Pharmaceuticals Cz S.R.O. report to view the information.
Financial Auditors:
Purchase the Dixons Pharmaceuticals Cz S.R.O. report to view the information.
Incorporation Date:
February 01, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dixons Pharmaceuticals Cz S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-29.28%
Total operating revenue
-29.28%
Operating profit (EBIT)
-63.61%
EBITDA
-63.61%
Net Profit (Loss) for the Period
-62.15%
Total assets
-21.63%
Total equity
-47.12%
Operating Profit Margin (ROS)
-7.51%
Net Profit Margin
-5.36%
Return on Equity (ROE)
-32.18%
Quick Ratio
-0.98%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?